Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT04592874
Brief Title: A Phase 2 Study to Evaluate Efficacy and Safety of AL002 in Participants With Early Alzheimer's Disease (INVOKE-2)

First Submitted : September 17, 2020
First Submitted that Met QC Criteria : October 13, 2020
First Posted : October 19, 2020

Last Update Submitted that Met QC Criteria : April 7, 2021
Last Update Posted : April 8, 2021